This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Grunenthal Gmbh. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Robert Kirby - Innovator in Pharmaceutical Chemistry
Introduction
Robert Kirby is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as voltage-gated calcium channel blockers. His work is essential in the ongoing search for effective treatments for pain and various diseases.
Latest Patents
Robert Kirby holds a patent for "Fluoromethyl-substituted pyrrole carboxamides." This invention relates to pyrrole carboxamides that bear a fluoromethyl moiety, which are utilized as voltage-gated calcium channel blockers. The patent also covers pharmaceutical compositions containing these compounds and their application in the treatment and/or prophylaxis of pain and other disorders.
Career Highlights
Robert Kirby is currently employed at Grünenthal GmbH, a company known for its focus on pain management and innovative pharmaceutical solutions. His work at Grünenthal has allowed him to contribute to the development of new therapeutic options that can improve patient outcomes.
Collaborations
Throughout his career, Robert has collaborated with talented professionals such as Stefan Schunk and Melanie Reich. These collaborations have fostered an environment of innovation and have led to advancements in the pharmaceutical field.
Conclusion
Robert Kirby's contributions to pharmaceutical chemistry, particularly through his patent on fluoromethyl-substituted pyrrole carboxamides, highlight his role as an innovator in the industry. His work continues to pave the way for new treatments that address significant health challenges.